trending Market Intelligence /marketintelligence/en/news-insights/trending/mmOcxHoJv2LLTJU1CGRDbA2 content esgSubNav
In This List

NanoString plans common stock offering to raise working capital

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond


NanoString plans common stock offering to raise working capital

NanoString Technologies Inc. plans to offer 4.5 million shares in an underwritten public offering.

Seattle-based NanoString will sell 2.5 million common shares, while private equity firm Clarus Lifesciences II LP, a NanoString stockholder, will sell 2 million shares. NanoString will not receive proceeds from the sale by Cambridge, Mass.-based Clarus.

Underwriters will have an option to buy up to 675,000 additional common shares.

NanoString plans to use net proceeds for working capital and general corporate purposes.

J.P. Morgan, UBS Investment Bank and Cowen are acting as joint book-running managers, with Baird acting as lead manager for the offering.

NanoString Technologies is a provider of life science tools for translational research and molecular diagnostic products.